The Role of Cellular Senescence in Cyclophosphamide-Induced Primary Ovarian Insufficiency
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242417193 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Zixin Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo 113-8655, Japan. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), Japan Society of Fertility Preservation, Japan Society for Menopause and Women’s Health (JMWH).
Abstract (Originalsprache)
Young female cancer patients can develop chemotherapy-induced primary ovarian insufficiency (POI). Cyclophosphamide (Cy) is one of the most widely used chemotherapies and has the highest risk of damaging the ovaries. Recent studies elucidated the pivotal roles of cellular senescence, which is characterized by permanent cell growth arrest, in the pathologies of various diseases. Moreover, several promising senolytics, including dasatinib and quercetin (DQ), which remove senescent cells, are being developed. In the present study, we investigated whether cellular senescence is involved in Cy-induced POI and whether DQ treatment rescues Cy-induced ovarian damage. Expression of the cellular senescence markers p16, p21, p53, and γH2AX was upregulated in granulosa cells of POI mice and in human granulosa cells treated with Cy, which was abrogated by DQ treatment. The administration of Cy decreased the numbers of primordial and primary follicles, with a concomitant increase in the ratio of growing to dormant follicles, which was partially rescued by DQ. Moreover, DQ treatment significantly improved the response to ovulation induction and fertility in POI mice by extending reproductive life. Thus, cellular senescence plays critical roles in Cy-induced POI, and targeting senescent cells with senolytics, such as DQ, might be a promising strategy to protect against Cy-induced ovarian damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
ORCID-Profile: Miyuki Harada, Osamu Wada-Hiraike
Förderung
- Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS)
- Japan Society of Fertility Preservation
- Japan Society for Menopause and Women’s Health (JMWH)
- IWAKI Foundation Scholarship
- ATSUMI International Foundation Scholarship
Zitieren
APA
Xu, Z., Takahashi, N., Harada, M., Kunitomi, C., Kusamoto, A., Koike, H., Tanaka, T., Sakaguchi, N., Urata, Y., Wada-Hiraike, O., Hirota, Y., & Osuga, Y. (2023). The Role of Cellular Senescence in Cyclophosphamide-Induced Primary Ovarian Insufficiency. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417193
Vancouver
Xu Z, Takahashi N, Harada M, Kunitomi C, Kusamoto A, Koike H, et al. The Role of Cellular Senescence in Cyclophosphamide-Induced Primary Ovarian Insufficiency. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417193
BibTeX
@article{Xu2023,
author = {Xu, Zixin and Takahashi, Nozomi and Harada, Miyuki and Kunitomi, Chisato and Kusamoto, Akari and Koike, Hiroshi and Tanaka, Tsurugi and Sakaguchi, Nanoka and Urata, Yoko and Wada-Hiraike, Osamu and Hirota, Yasushi and Osuga, Yutaka},
title = {The Role of Cellular Senescence in Cyclophosphamide-Induced Primary Ovarian Insufficiency},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242417193}
}
EUVIMED